2010
DOI: 10.1016/j.cej.2010.06.022
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic synthesis of amorphous cefuroxime axetil nanoparticles with size-dependent and enhanced dissolution rate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
27
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(28 citation statements)
references
References 39 publications
0
27
0
1
Order By: Relevance
“…In response, several studies have investigated a number of techniques to enhance drug solubility (Aldawsari et al, 2013;Charoenchaitrakool et al, 2000;Chen et al, 2015;Fujimori et al, 2015;Sanphui et al, 2011;Serajuddin, 2007;Wang et al, 2010). Nonetheless, a number of compounds have great potential applicability in co-crystallization due to the existence of non-covalent bonds between molecules in co-crystals.…”
Section: Introductionmentioning
confidence: 98%
“…In response, several studies have investigated a number of techniques to enhance drug solubility (Aldawsari et al, 2013;Charoenchaitrakool et al, 2000;Chen et al, 2015;Fujimori et al, 2015;Sanphui et al, 2011;Serajuddin, 2007;Wang et al, 2010). Nonetheless, a number of compounds have great potential applicability in co-crystallization due to the existence of non-covalent bonds between molecules in co-crystals.…”
Section: Introductionmentioning
confidence: 98%
“…Some examples of nanoprecipitation using different kinds of microfluidic devices can be found in the literature, such as amorphous cefuroxime axetil prepared by nanoprecipitation to enhance the dissolution rate, using a Y-junction microreactor [21] and a T-junction microreactor [22]. The authors observed that the total fluid flow rate, the antisolvent to solvent flow rate The manuscript was received on July 31, 2013; revision received on September 2, 2013; accepted on September 3, 2013 ratio, and the cefuroxime concentration, all influence particle size.…”
Section: Introductionmentioning
confidence: 99%
“…In another study, it was shown that design of microreactor and processing conditions may have an influence on the hydrocortisone particle size during nanoprecipitation using microfluidic reactors (18). Also, microfluidic nanoprecipitation of the other pharmaceutical ingredients such as danazol (20), norfloxacin (15), cefuroxime axetil (16), and rifampicin (17) have shown the creation of drug particles with controlled sizes, improved dissolution rate, continuous synthesis, and amorphous profile.…”
Section: Introductionmentioning
confidence: 99%
“…Effects of changing the various parameters of the microfluidic precipitation process, including flow rate of drug solution and antisolvent, drug saturation level, channels internal diameter, microreactor inlet angle, drug concentration, precipitation temperature, and surfactant concentration, on the size of nanosized drug particles have been evaluated widely in previous studies (15)(16)(17)(18)(19)(20). It is observed that increasing in the flow rate of antisolvent and decreasing in the flow rate of drug solution, sharpen inlet angles and lessen saturation levels resulted in smaller particle sizes (19).…”
Section: Introductionmentioning
confidence: 99%